Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_provenance.
- NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_assertion description "[Sustained activation, overexpression, or mutation of the MET pathway is associated with a poor prognosis in a variety of tumors, including non-small cell lung cancer (NSCLC), implicating the MET pathway as a potential therapeutic target for lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_provenance.
- NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_assertion evidence source_evidence_literature NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_provenance.
- NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_assertion SIO_000772 23989980 NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_provenance.
- NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_assertion wasDerivedFrom befree-2016 NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_provenance.
- NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_assertion wasGeneratedBy ECO_0000203 NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_provenance.
- befree-2016 importedOn "2016-02-19" NP1106401.RAOi7tuS0-6cBgXSJ8K9-_du2Qkxp1B49cQ4reEemb90Y130_provenance.